Vendor, Deerfield, IL
Baxalta US Inc.
UEI LT5GEHL2F1K6, CAGE 7CZJ7
1 award and -$11,867 obligated between April 15, 2026 and April 15, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | -$11,867 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Delivery Order | 1 |
Hear when Baxalta US Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Baxalta US Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling pharmaceutical preparation manufacturing to National Institutes of Health, by dollars.
| DLA Troop SupportPhiladelphia, PA | $252,943,801 |
| Pine Pharmaceuticals LLCTonawanda, NY | $1,258,030 |
| United Biopharma, Inc.Hsinchu County | $400,000 |
| Vitae Enim Vitae Scientific, Inc.San Diego, CA | $382,010 |
| On Demand Pharmaceuticals Inc.Rockville, MD | $325,000 |
| Lantheus Biosciences Ltd.Warwick | $248,300 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N90020F00139Delivery Order, April 15, 2026, Full and Open Competition, 1 offers | National Institutes of Health - CCNational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 325412, PSC 6505 | -$11,867 |
- Places of performance
- Illinois
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 1 across 1 awards